Want to join the conversation?
In 1Q16, $WFM produced an 8.3% EBITDA margin, $53MM in free cash flow, and a 14% adjusted ROIC. SG&A cost savings, mainly salaries and benefits, were offset by investments in value and technology as well as deleverage in areas like occupancy and depreciation, which resulted in a 58-BP decline in operating margin.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?